| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.3M | -58.6% | -78.8% |
| R&D Expense | $29.4M | +6.3% | -38.9% |
| SG&A Expense | $11.5M | -20.0% | -27.0% |
| Operating Income | -$37.6M | -10.2% | +22.4% |
| Pre-tax Income | -$34.7M | -13.6% | +17.9% |
| Income Tax | $0 | — | — |
| Net Income | -$34.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $76.5M | +70.9% | +105.9% |
| Short-term Investments | $214.6M | -18.2% | -48.9% |
| Current Assets | $300.4M | -5.9% | -36.0% |
| Total Assets | $335.3M | -5.9% | -35.0% |
| Current Liabilities | $80.0M | -5.2% | -43.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$142.3M | — | — |
| Capital Expenditures | $41K | — | — |
| Investing Cash Flow | $171.0M | — | — |
| Financing Cash Flow | $14.8M | — | — |
| Free Cash Flow | -$142.4M | — | — |
| +17.9% |
| EPS (Basic) | -$0.34 | -13.3% | +20.9% |
| EPS (Diluted) | -$0.34 | -13.3% | +20.9% |
| $9.6M |
| +0.8% |
| — |
| Total Liabilities | $277.6M | -2.7% | -30.1% |
| Stockholders' Equity | $57.7M | -18.9% | -51.5% |